Adam Hayes, Ph.D., CFA, is a financial writer with 15+ years Wall Street experience as a derivatives trader. Besides his extensive derivative trading expertise, Adam is an expert in economics and ...

IQM valued at $1.8 billion in SPAC merger No current projects seek US federal stakes, CEO says Aims to list shares in Helsinki, first European quantum company BRUSSELS, HELSINKI, Feb 23 (Reuters) - ...

Alysa Liu has been on the Olympics stage before, but a lot has changed since her last performance in 2022. She actually retired temporarily and has now come back with a new mindset for the 2026 Games.

Qatar announced two new 10-year golden visa pathways aimed at entrepreneurs and executives, without requiring investment for long-term residency. Here’s what to know. If you're looking to start or ...

SpaceX has acquired xAI, the company announced on Monday, merging two of Elon Musk’s most ambitious companies into the most valuable private company in the world. “This marks not just the next chapter ...

Blue Origin has “paused” its New Shepard program for the next two years, a move that likely signals a permanent end to the suborbital space tourism initiative. The small rocket and capsule have been ...

Meghana Keshavan covers biotech and contributes to The Readout newsletter. Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

Jan 15 (Reuters) - The U.S. Food and Drug Administration has delayed reviews of two drugs chosen for the Trump administration's ‌new fast-track program after agency scientists flagged safety and ...